AstraZeneca to decarbonize U.S. footprint by turning cow manure into renewable natural gas

In a first for the pharma sector, AstraZeneca will tap renewable natural gas for its U.S. manufacturing sites by the end of 2026.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.